07:00 - 08:15 | 83 | CC2 Children’s interstitial lung disease | Challenging clinical cases |
07:00 - 08:15 | 90 | CC1 Breathless cases | Challenging clinical cases |
08:00 - 10:20 | 107 | SW4 Difficult airway management in an intensive care unit | Skills workshop |
08:00 - 10:20 | 108 | SW5 Thoracic ultrasound | Skills workshop |
08:30 - 10:30 | 109 | Scientific Year in Review 2016 | Year in review |
08:30 - 10:30 | 110 | COPD case-finding: how can we find the missing millions? | Symposium |
08:30 - 10:30 | 111 | Lung involvement in systemic disorders | Symposium |
08:30 - 10:30 | 112 | ERS-ALAT-SBPT-SEPAR-SPP joint session: Spanish and Portuguese Session I | Session |
08:30 - 10:30 | 113 | Nerves in airway disease: genotype, phenotype and endotype | Symposium |
08:30 - 10:30 | 114 | Immunotherapy: the lethal weapon against thoracic malignancies? | Symposium |
08:30 - 10:30 | 115 | ERS publications: a focus on recent guidelines and task forces | Session |
08:30 - 10:30 | 116 | Origins of infant pulmonary disease: early pointers for identifying infants at risk and ways to improve their care | Oral Presentation |
08:30 - 10:30 | 117 | Best abstracts in asthma and COPD | Oral Presentation |
08:30 - 10:30 | 118 | Clinic of pulmonary hypertension | Oral Presentation |
08:30 - 10:30 | 119 | Best abstracts in pulmonary rehabilitation and chronic care | Oral Presentation |
08:30 - 10:30 | 120 | Clinical update on bronchiectasis | Oral Presentation |
08:30 - 10:30 | 121 | The best is yet to come in terms of lung function | Oral Presentation |
08:30 - 10:30 | 122 | Respiratory nursing research: opening new perspectives on patient experiences | Oral Presentation |
08:30 - 10:30 | 123 | Pharmacological management of COPD | Poster Discussion |
08:30 - 10:30 | 124 | Paediatric asthma: lessons learned from studies with large sample sizes and multi-centre drug studies | Poster Discussion |
08:30 - 10:30 | 125 | Epidemiological aspects of obstructive sleep apnoea | Poster Discussion |
08:30 - 10:30 | 126 | Infections, sepsis, and pulmonary embolism | Poster Discussion |
08:30 - 10:30 | 127 | Advanced lung function testing in childhood respiratory and sleep disease | Poster Discussion |
08:30 - 10:30 | 128 | Human responses to exposure, including physiological and biomarker outcomes | Poster Discussion |
09:00 - 16:00 | 130 | PD2 EBUS train the trainer | Professional development workshop |
10:40 - 13:00 | 137 | SW6 Difficult airway management in an intensive care unit | Skills workshop |
10:40 - 13:00 | 138 | SW7 Thoracic ultrasound | Skills workshop |
10:45 - 12:45 | 139 | GR1 Paediatric Grand Round | Grand round |
10:45 - 12:45 | 140 | ERS and tuberculosis | Symposium |
10:45 - 12:45 | 141 | New statement on pulmonary rehabilitation | Symposium |
10:45 - 12:45 | 142 | ERS-ALAT-SBPT-SEPAR-SPP joint session: Spanish and Portuguese Session II | Session |
10:45 - 12:45 | 143 | State-of-the-art research techniques in Royal Brompton Hospital and Imperial College London I | Session |
10:45 - 12:45 | 144 | Telemonitoring of ventilator-dependent patients | Symposium |
10:45 - 12:45 | 145 | New insights into the genetics of asthma | Symposium |
10:45 - 12:45 | 146 | Population-based insights into occupational and environmental lung disease | Oral Presentation |
10:45 - 12:45 | 147 | New therapies and therapeutic targets | Oral Presentation |
10:45 - 12:45 | 148 | Endoscopic lung volume reduction I | Oral Presentation |
10:45 - 12:45 | 149 | IPF pathogenesis | Oral Presentation |
10:45 - 12:45 | 150 | Inflammatory biomarkers in airway diseases | Oral Presentation |
10:45 - 12:45 | 151 | Mesothelioma and pleural disease: from the bench to the bedside | Oral Presentation |
10:45 - 12:45 | 152 | Repair pathways: from lung development to ageing of the lung | Oral Presentation |
10:45 - 12:45 | 153 | Lung cancer and immune cells: friends or foes? | Poster Discussion |
10:45 - 12:45 | 154 | Effects of exercise training interventions in chronic respiratory disease | Poster Discussion |
10:45 - 12:45 | 155 | In-patient and out-patient COPD management | Poster Discussion |
10:45 - 12:45 | 156 | Asthma: mechanisms and biomarkers that promote clinical understanding | Poster Discussion |
10:45 - 12:45 | 157 | Special issues in thoracic surgery | Poster Discussion |
10:45 - 12:45 | 158 | Community-acquired pneumonia: from prevention to treatment | Poster Discussion |
12:50 - 14:40 | 165 | Clinical characteristics of asthma | Thematic Poster |
12:50 - 14:40 | 166 | Features and impact of comorbidities in COPD | Thematic Poster |
12:50 - 14:40 | 167 | From pleura to bronchi: new insights | Thematic Poster |
12:50 - 14:40 | 168 | Latest insights into pulmonary rehabilitation | Thematic Poster |
12:50 - 14:40 | 169 | Latest insights into functional capacity and muscle weakness in chronic lung diseases | Thematic Poster |
12:50 - 14:40 | 170 | Best abstracts in COPD management | Thematic Poster |
12:50 - 14:40 | 171 | Imaging of COPD and airways: structural and functional assessments | Thematic Poster |
12:50 - 14:40 | 172 | Bronchoscopy: from diagnostic to treating air leaks | Thematic Poster |
12:50 - 14:40 | 173 | IPF: from pathogenesis to treatment I | Thematic Poster |
12:50 - 14:40 | 174 | Clinical aspects of ILD | Thematic Poster |
12:50 - 14:40 | 175 | Sarcoidosis | Thematic Poster |
12:50 - 14:40 | 176 | Asthma management in primary care | Thematic Poster |
12:50 - 14:40 | 177 | Managing multimorbidity and lifestyle change in primary care | Thematic Poster |
12:50 - 14:40 | 178 | Molecular targets in pulmonary disease | Thematic Poster |
12:50 - 14:40 | 179 | What's new in biomarker analysis? | Thematic Poster |
12:50 - 14:40 | 180 | Translational studies in lung disease | Thematic Poster |
12:50 - 14:40 | 181 | Novel insights into alveolar and bronchial epithelial cell injury and repair | Thematic Poster |
12:50 - 14:40 | 182 | Pulmonary drug delivery | Thematic Poster |
12:50 - 14:40 | 183 | Pharmacological treatment of COPD: focus on LABA/LAMA combinations | Thematic Poster |
12:50 - 14:40 | 184 | Systemic biomarkers | Thematic Poster |
12:50 - 14:40 | 185 | Non-inflammatory assessment of airway disorders | Thematic Poster |
12:50 - 14:40 | 186 | Monitoring airway diseases with clinical tools | Thematic Poster |
12:50 - 14:40 | 187 | Airway biomarkers | Thematic Poster |
12:50 - 14:40 | 188 | Laboratory tests and cell biology in allergy and immunology | Thematic Poster |
12:50 - 14:40 | 189 | Pharmacological intervention in humans and murine models of asthma | Thematic Poster |
12:50 - 14:40 | 190 | Comorbidities and exacerbations in COPD | Thematic Poster |
12:50 - 14:40 | 191 | Asthma, COPD, and ACOS: physical activity, dietary aspects, and diseases burden | Thematic Poster |
12:50 - 14:40 | 192 | Occupational epidemiology | Thematic Poster |
12:50 - 14:40 | 193 | Public health related concerns and epidemiology of smoking and smoking-related products | Thematic Poster |
12:50 - 14:40 | 194 | Role of genetics and exposures in COPD and asthma | Thematic Poster |
12:50 - 14:40 | 195 | What's new in paediatric respiratory physiology? | Thematic Poster |
12:50 - 14:40 | 196 | Drugs, bugs, BMI, and other problems in paediatric asthma | Thematic Poster |
12:50 - 14:40 | 197 | Cystic fibrosis: various aspects | Thematic Poster |
12:50 - 14:40 | 198 | Paediatric respiratory infections | Thematic Poster |
12:50 - 14:40 | 199 | Neonatal and paediatric multiorgan manifestations of acute and chronic pulmonary disease and use of treatments | Thematic Poster |
12:50 - 14:40 | 200 | Asthma, bronchiectasis, and the risk factors for respiratory morbidity | Thematic Poster |
12:50 - 14:40 | 201 | Quality and quantity in lung function | Thematic Poster |
12:50 - 14:40 | 202 | Postural balance, respiratory muscles, and comorbidities in chronic respiratory disease | Thematic Poster |
12:50 - 14:40 | 203 | Physiotherapy management of the ill but spontaneously-breathing adult patient | Thematic Poster |
12:50 - 14:40 | 204 | The wide spectrum of respiratory nursing research and practice: across all ages and diseases | Thematic Poster |
13:00 - 14:30 | 206 | Climate change and respiratory health | Lunchtime session |
13:00 - 14:30 | 207 | AJRCCM Blue Journal in 2016: a joint ERS lunchtime session | Lunchtime session |
13:00 - 14:30 | 208 | Vitamin D and asthma prevention, COPD screening, and bronchoscopic lung volume reduction in emphysema | Lunchtime session |
13:00 - 14:00 | 215 | ME4 Pulmonary arteriovenous malformations | Meet the expert |
13:00 - 14:00 | 216 | ME2 New treatment approaches for idiopathic pulmonary fibrosis | Meet the expert |
13:00 - 14:00 | 217 | ME1 Biomarkers for interstitial lung disease | Meet the expert |
13:00 - 14:00 | 218 | ME3 Fiberoptic bronchoscopy in children | Meet the expert |
14:30 - 16:50 | 231 | SW8 Difficult airway management in an intensive care unit | Skills workshop |
14:30 - 16:50 | 232 | SW9 Thoracic ultrasound | Skills workshop |
14:45 - 16:45 | 234 | GR2 Radiology | Grand round |
14:45 - 16:45 | 235 | Is sleep apnoea causing cancer? | Hot topics |
14:45 - 16:45 | 236 | Traffic air pollution in urban areas | Hot topics |
14:45 - 16:45 | 237 | Childhood asthma causation | Symposium |
14:45 - 16:45 | 238 | New tools for the early diagnosis of acute respiratory distress syndrome | Symposium |
14:45 - 16:45 | 239 | Implementation of collaborative lung function testing | Symposium |
14:45 - 16:45 | 240 | Complications and comorbidities in idiopathic pulmonary fibrosis | Symposium |
14:45 - 16:45 | 241 | Molecular pathways of smoking-induced diseases | Oral Presentation |
14:45 - 16:45 | 242 | Cystic fibrosis: monitoring and management | Oral Presentation |
14:45 - 16:45 | 243 | Paediatric bronchology I | Oral Presentation |
14:45 - 16:45 | 244 | Highlights in the management of COPD and beyond | Oral Presentation |
14:45 - 16:45 | 245 | Advances in tuberculosis diagnosis and monitoring of treatment | Oral Presentation |
14:45 - 16:45 | 246 | Best abstracts on the role of exercise and physical activity in chronic respiratory disease | Oral Presentation |
14:45 - 16:45 | 247 | Late-breaking translational research in lung cancer | Oral Presentation |
14:45 - 16:45 | 248 | How the increasing complexity of chronic care management challenges ethics and costs in our healthcare system | Poster Discussion |
14:45 - 16:45 | 249 | Possible phenotypes of bronchiectasis and exacerbations | Poster Discussion |
14:45 - 16:45 | 250 | Best abstracts in exercise capacity and testing in chronic lung diseases | Poster Discussion |
14:45 - 16:45 | 251 | Unmasking the mechanisms of symptoms and exercise limitation in disease | Poster Discussion |
14:45 - 16:45 | 252 | Paediatric respiratory infection | Poster Discussion |
14:45 - 16:45 | 253 | Kaleidoscope of respiratory nursing | Poster Discussion |